Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9K Sell
219
-168
-43% -$15.3K ﹤0.01% 505
2026
Q1
$39.7K Buy
387
+48
+14% +$5.42K ﹤0.01% 439
2025
Q4
$42.5K Hold
339
﹤0.01% 416
2025
Q3
$45.4K Hold
339
﹤0.01% 412
2025
Q2
$46.1K Hold
339
0.01% 397
2025
Q1
$45K Hold
339
0.01% 384
2024
Q4
$38.3K Sell
339
-128
-27% -$14.8K ﹤0.01% 396
2024
Q3
$53.2K Hold
467
0.01% 376
2024
Q2
$48.5K Sell
467
-100
-18% -$10.6K 0.01% 365
2024
Q1
$64.4K Buy
567
+100
+21% +$11.5K 0.01% 359
2023
Q4
$51.4K Buy
+467
New +$46.7K 0.01% 354

Other funds holding ABT

BFSG LLC's ABT Position: Q2 2026 in Review

BFSG LLC reduced its Abbott (ABT) stake by 43% in Q2 2026, selling an estimated $15.3K and leaving 219 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #505.

BFSG LLC first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $64.4K in Q1 2024. 684 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • BFSG LLC held 219 shares of Abbott worth $19.9K as of Q2 2026.
  • BFSG LLC sold 168 Abbott shares in Q2 2026, an estimated $15.3K.
  • Abbott made up ﹤0.01% of BFSG LLC's portfolio in Q2 2026, its #505 holding.
  • BFSG LLC first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • BFSG LLC's Abbott position peaked at $64.4K in Q1 2024.
  • 684 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.